diadenosine tetraphosphate has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CF; Chen, S; Chiang, YH; Harvey, BK; Morales, M; Su, TP; Thiemermann, C; Tsao, LI; Wang, Y | 1 |
| Hoyle, CH; Pintor, JJ | 1 |
2 other study(ies) available for diadenosine tetraphosphate and oxidopamine
| Article | Year |
|---|---|
Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain.
Topics: Animals; Apoptosis; Blood Pressure; Brain Ischemia; Cell Hypoxia; Cells, Cultured; Cerebral Cortex; Cerebral Infarction; Dinucleoside Phosphates; Dopamine; Hypokinesia; Locomotion; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats; Receptors, Purinergic; Regional Blood Flow; Stroke | 2003 |
Diadenosine tetraphosphate protects sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye.
Topics: Adrenergic Agents; Animals; Aqueous Humor; Dinucleoside Phosphates; Eye; Humans; Male; Neuroprotective Agents; Oxidopamine; Platelet Aggregation Inhibitors; Rabbits; Sympathetic Fibers, Postganglionic; Synapses; Tears; Vesicular Monoamine Transport Proteins | 2010 |